Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

CANCER researchers seeking non-toxic alternatives to harmful chemotherapy are reporting a highly significant result for a humble cold remedy.

20 Nov 2017

Study explores feasibility of mainstreaming genetic counseling for ovarian cancer

A study that looked at mainstreaming genetic counseling for ovarian cancer to support screening programs in Malaysia was presented at the ESMO Asia 2017 Congress.

20 Nov 2017

Cancer drugs may offer new way to control high blood pressure

Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.

20 Nov 2017

Study highlights need for early identification, treatment of PTSD in cancer survivors

A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later.

20 Nov 2017

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine.

20 Nov 2017

All mouth cancer patients in Myanmar use smokeless tobacco, study finds

A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia 2017 Congress. Betel quid chewing often starts in adolescence and is associated with smoking and drinking alcohol, which are also risk factors for oral cancer.

20 Nov 2017

Indonesian study finds low rates of awareness about cervical and breast cancer screening

Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress. The research in nearly 5,400 women also found that only 5% knew about mammography for early detection of breast cancer.

20 Nov 2017

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

A randomized trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

Researchers receive £1.3 million to develop sight-saving imaging technology

Staff at the University of Liverpool's Department of Eye & Vision Science have been awarded £1.3 million by the National Institute for Health Research's Intervention for Innovation (i4i) program to develop a state-of-the-art Ultra-Sensitive Optical Coherence Tomography system.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

Researchers develop computer program to find new indications for old drugs

Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.

16 Nov 2017

UNT professor develops alternative to anesthesia for pediatric cancer patients undergoing radiation

While radiation therapy is the most common cancer treatment for children under age 10, preparation for it may cause great stress for a child and his or her family.

16 Nov 2017

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help physicians make better treatment choices for patients with gastric and esophageal adenocarcinoma.

15 Nov 2017

Changes in multiple different genes drive world's most deadly forms of lung cancer

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world's most deadly forms of lung cancer is driven by changes in multiple different genes, which appear to work together to drive cancer progression and to allow tumors to evade targeted therapy.

15 Nov 2017

WFIRM-led project aims to study health risks astronauts face from exposure to space radiation

The Wake Forest Institute for Regenerative Medicine has been selected by NASA to lead a multi-institutional project to better understand the health risks astronauts face from the exposure to galactic cosmic ray (GCR) and solar energetic particle (SEP) radiation that occurs from long-duration missions in deep space, and to develop countermeasures to keep astronauts safe.

14 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Newly published research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease (GvHD), a potentially lethal complication of bone marrow stem cell (BMSC) transplantation.

14 Nov 2017

Oncology News and Research

Further Reading

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

Study explores feasibility of mainstreaming genetic counseling for ovarian cancer

Cancer drugs may offer new way to control high blood pressure

Study highlights need for early identification, treatment of PTSD in cancer survivors

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

All mouth cancer patients in Myanmar use smokeless tobacco, study finds

Indonesian study finds low rates of awareness about cervical and breast cancer screening

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers receive £1.3 million to develop sight-saving imaging technology

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves new drug to treat bleeding in hemophilia A patients

Researchers develop computer program to find new indications for old drugs

UNT professor develops alternative to anesthesia for pediatric cancer patients undergoing radiation

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

Changes in multiple different genes drive world's most deadly forms of lung cancer

WFIRM-led project aims to study health risks astronauts face from exposure to space radiation

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News